Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    April 2018
  1. JAZZAR U, Yong S, Klaassen Z, Huo J, et al
    Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31404.
    PubMed     Text format     Abstract available


  2. CORREA AF, Smaldone MC
    Melancholia and cancer: The bladder cancer narrative.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31402.
    PubMed     Text format    


    January 2018
  3. CHOUDHURY A, Hoskin PJ
    Bladder cancer and the National Cancer Data Base: New insight or misinformation?
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31210.
    PubMed     Text format    


    December 2017
  4. WELTY CJ, Sanford TH, Wright JL, Carroll PR, et al
    The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
    Cancer. 2017;123:4574-4582.
    PubMed     Text format     Abstract available


    July 2017
  5. CAHN DB, Handorf EA, Ghiraldi EM, Ristau BT, et al
    Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30900.
    PubMed     Text format     Abstract available


  6. VETTERLEIN MW, Wankowicz SAM, Seisen T, Lander R, et al
    Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30907.
    PubMed     Text format     Abstract available


  7. KOPP RP, Stratton KL, Glogowski E, Schrader KA, et al
    Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Cancer. 2017;123:2452-2458.
    PubMed     Text format     Abstract available


  8. PIATON E, Advenier AS, Carre C, Decaussin-Petrucci M, et al
    p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Cancer. 2017;125:552-562.
    PubMed     Text format     Abstract available


    June 2017
  9. OJERHOLM E, Smith A, Hwang WT, Christodouleas JP, et al
    Reply to Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30871.
    PubMed     Text format    


  10. DOLAN RD, McMillan DC
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30872.
    PubMed     Text format    


  11. KORPICS MC, Block AM, Martin B, Hentz C, et al
    Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30719.
    PubMed     Text format     Abstract available


  12. RIMAR KJ, Tran PT, Matulewicz RS, Hussain M, et al
    The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
    Cancer. 2017;123:1912-1924.
    PubMed     Text format     Abstract available


  13. SCOTT SN, Ostrovnaya I, Lin CM, Bouvier N, et al
    Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guerin.
    Cancer. 2017;125:416-426.
    PubMed     Text format     Abstract available


    February 2017
  14. PACKIAM VT, Johnson SC, Steinberg GD
    Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin.
    Cancer. 2017;123:390-400.
    PubMed     Text format     Abstract available


  15. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Text format     Abstract available


  16. MACLEOD LC, Pham KN, Agoff SN, Dahl KL, et al
    Cytologic persistence of malignant cells after transurethral resection of bladder tumors: Implications for concomitant manipulation of the urinary tract at the time of endoscopic resection.
    Cancer. 2017;125:114-119.
    PubMed     Text format     Abstract available


    October 2016
  17. OJERHOLM E, Smith A, Hwang WT, Baumann BC, et al
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30422.
    PubMed     Text format     Abstract available


    August 2016
  18. PRINTZ C
    Arsenic in private well water may contribute to bladder cancer risk.
    Cancer. 2016;122:2291.
    PubMed     Text format    


  19. DESAI NB, Scott SN, Zabor EC, Cha EK, et al
    Genomic characterization of response to chemoradiation in urothelial bladder cancer.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30219.
    PubMed     Text format     Abstract available


    May 2016
  20. ROSE TL, Deal AM, Nielsen ME, Smith AB, et al
    Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer.
    Cancer. 2016 May 25. doi: 10.1002/cncr.30029.
    PubMed     Text format     Abstract available


  21. HARSHMAN LC
    Mind the gap: What is driving the survival disparity between the sexes in bladder cancer?
    Cancer. 2016 May 25. doi: 10.1002/cncr.30027.
    PubMed     Text format    


    March 2016
  22. ROSS JS, Wang K, Khaira D, Ali SM, et al
    Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
    Cancer. 2016;122:702-11.
    PubMed     Text format     Abstract available


  23. TULLY CM, Apolo AB, Zabor EC, Regazzi AM, et al
    The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
    Cancer. 2016;122:712-21.
    PubMed     Text format     Abstract available


    January 2016
  24. CHOU R, Selph SS, Buckley DI, Gustafson KS, et al
    Treatment of muscle-invasive bladder cancer: A systematic review.
    Cancer. 2016 Jan 15. doi: 10.1002/cncr.29843.
    PubMed     Text format     Abstract available


    December 2015
  25. GREEN AK, Milowsky MI
    Genomic profiling of advanced bladder cancer to guide the use of targeted therapeutics.
    Cancer. 2015 Dec 9. doi: 10.1002/cncr.29825.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: